GlassScriptPhysician profile
Kacey Montgomery
NPI 1447455977
$3,546.16
in general payments reported to CMS, 2019-2025
22 companies · $417 in 2025
The $417 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $278 · 2021: $596 · 2022: $678 · 2023: $622 · 2024: $738 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,777.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,006.60 | 2021-2025 | Intracept, Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Abbott Laboratories | $807.80 | 2019-2025 | Eterna, Octrode, Proclaim |
| Nevro Corp. | $782.17 | 2021-2024 | Senza |
| Medtronic, INC. | $177.99 | 2021-2022 | |
| Fidia Pharma USA INC. | $125.41 | 2019-2023 | Triluron |
| Vertos Medical, INC. | $120.62 | 2024 | Mild Device Kit |
| Relievant Medsystems, INC. | $79.62 | 2023 | Intracept |
| Stimwave Technologies Incorporated | $67.76 | 2022 | |
| Medtronic USA, INC. | $63.18 | 2020 | |
| Collegium Pharmaceutical, INC. | $55.15 | 2019-2024 | Belbuca |
| Saluda Medical Americas, INC. | $33.19 | 2025 | Evoke |
| Amgen INC. | $32.63 | 2021 | |
| Scilex Pharmaceuticals INC. | $31.10 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.99 | 2021-2025 | Relistor |
| Orthogenrx INC. | $23.78 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $22.06 | 2021 | |
| Horizon Therapeutics Plc | $17.13 | 2022 | |
| Almatica Pharma LLC | $16.09 | 2022 | |
| Averitas Pharma INC. | $14.94 | 2023 | Qutenza |
| Flowonix Medical Incorporated | $14.38 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.51 | 2019 | |
| Biodelivery Sciences International, INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kacey Montgomery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.